DexCom, Inc. (DXCM)

DexCom, Inc., headquartered in San Diego, California, is a global leader in continuous glucose monitoring (CGM) systems for people with diabetes. Led by CEO Kevin Sayer, the company’s strategy centers on "Expanding Access"—moving from a niche provider for Type 1 diabetes to a broad-market leader for Type 2 and non-insulin-using populations. Their flagship strategy revolves around the "G7" and the newly launched "Stelo" over-the-counter CGM. DexCom is utilizing AI and data partnerships (with Apple and Garmin) to provide real-time metabolic insights. Their mission is to empower people to take control of their health through innovative CGM technology, focusing on driving global adoption and integrating their data into the broader "Connected Health" and GLP-1 therapy ecosystems.